切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - RET - Monocarboxylate transporters (MCTs) - Abl kinases - 5-HT1 Receptor

10 件产品

每页
清除全部
  1. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  2. Methylergometrine maleate
    B6347 Methylergometrine maleate
    中文名: 马来酸甲麦角新碱
    Target: 5-HT1 Receptor|5-HT2 Receptor
    Summary: 5-HT1/5-HT2受体拮抗剂
      Soluble to 25 mM in H2O
  3. Naratriptan
    B2251 Naratriptan
    中文名: 盐酸那拉曲坦,盐酸纳拉曲坦
    Target: 5-HT1 Receptor
    Summary: 选择性5-HT1受体亚型激动剂
      ≥61.1 mg/mL
      insoluble in H2O
  4. PPY A
    A8607 PPY A
    Target: Abl kinases
    Summary: Abl激酶抑制剂
      <37.24 mg/mL
  5. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  6. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  7. UK-5099
    A3899 UK-5099
     1 Citation
    Target: Monocarboxylate transporters (MCTs)|mitochondrial pyruvate carrier (MPC)
    Summary: MCTs和MPC抑制剂
      ≥28.8 mg/mL
      insoluble in H2O
  8. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  9. AR-C155858
    A3185 AR-C155858
    Target: Monocarboxylate transporters (MCTs)
    Summary: MCT1和MCT2抑制剂
      ≥52.5 mg/mL
      insoluble in H2O
  10. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Aurora A/Flt3的选择性抑制剂
      ≥18.75 mg/mL
      insoluble in H2O

10 件产品

每页